Natus Medical to Hold 2020 Third Quarter Financial Results Conference Call on October 29th
PLEASANTON, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) — Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider […]
Navient appoints Joe Fisher as new CFO
WILMINGTON, Del., Oct. 06, 2020 (GLOBE NEWSWIRE) — Navient (Nasdaq: NAVI), a leader in education loan management and business processing […]
CytomX Therapeutics Announces the Planned Retirement of Chief Scientific Officer, W. Michael Kavanaugh, M.D.
Marcia P. Belvin, Ph.D., Promoted to Senior Vice President, Head of ResearchDr. Kavanaugh to Join CytomX Scientific Advisory BoardSOUTH SAN […]
Processa Pharmaceuticals Closes $19.2 Million Public Offering
HANOVER, MD, Oct. 06, 2020 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company focused on the […]
Oaktree Specialty Lending Corporation Schedules Fourth Fiscal Quarter and Full Year 2020 Earnings Conference Call for November 19, 2020
11:00 a.m. Eastern Time / 8:00 a.m. Pacific TimeLOS ANGELES, CA, Oct. 06, 2020 (GLOBE NEWSWIRE) — Oaktree Specialty Lending […]
Arcutis Biotherapeutics Announces Closing of Public Offering and Concurrent Private Placement of Common Stock
WESTLAKE VILLAGE, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on […]
Oaktree Strategic Income Corporation Schedules Fourth Fiscal Quarter and Full Year 2020 Earnings Conference Call for November 19, 2020
12:30 p.m. Eastern Time / 9:30 a.m. Pacific TimeLOS ANGELES, CA, Oct. 06, 2020 (GLOBE NEWSWIRE) — Oaktree Strategic Income […]
Eton Pharmaceuticals Submits New Drug Application to the FDA for Topiramate Oral Solution (ET-101)
– Application Submitted for the Treatment of Partial-Onset Seizures and Migraine– Eton’s Patent-Pending Product Addresses Significant Unmet Need for a […]
Landec Corporation Reports First Quarter Fiscal Year 2021 Results
SANTA MARIA, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) — Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with […]
C4 Therapeutics Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
WATERTOWN, Mass., Oct. 06, 2020 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a biopharmaceutical company pioneering a new […]
